Viveve Medical (NASDAQ: VIVE) and Zynex (OTCMKTS:ZYXI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, dividends, risk and earnings.
Volatility and Risk
Viveve Medical has a beta of -0.44, suggesting that its stock price is 144% less volatile than the S&P 500. Comparatively, Zynex has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500.
Insider and Institutional Ownership
40.6% of Viveve Medical shares are held by institutional investors. Comparatively, 0.0% of Zynex shares are held by institutional investors. 35.1% of Viveve Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Earnings and Valuation
This table compares Viveve Medical and Zynex’s gross revenue, earnings per share and valuation.
||Earnings Per Share
Zynex has higher revenue and earnings than Viveve Medical. Viveve Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.
This table compares Viveve Medical and Zynex’s net margins, return on equity and return on assets.
||Return on Equity
||Return on Assets
This is a breakdown of current ratings and target prices for Viveve Medical and Zynex, as provided by MarketBeat.
||Strong Buy Ratings
Viveve Medical currently has a consensus price target of $9.33, suggesting a potential upside of 388.66%. Given Viveve Medical’s stronger consensus rating and higher probable upside, research analysts plainly believe Viveve Medical is more favorable than Zynex.
Zynex beats Viveve Medical on 9 of the 14 factors compared between the two stocks.
About Viveve Medical
Viveve Medical, Inc. designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable accessories. It markets its products through sales employees and distributors in the United States, the Asia Pacific, Europe, the Middle East, Latin America, and Canada. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
Zynex, Inc., a medical technology company, designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. Its products include NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; and InWave, an electrical stimulation product for the treatment of female urinary incontinence. The company also distributes private labeled products, such as electrodes for the delivery of electrical current to the body; batteries for use in electrotherapy products; Comfortrac for cervical traction; JetStream for hot/cold therapy; and LSO Back Braces for lumbar support. In addition, it develops non-invasive blood volume monitors for use in hospitals and surgery centers. The company offers its products for pain management and control; and stroke and spinal cord injury rehabilitation. It sells its products through direct and independent sales representatives primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.